The Evolution of Vesicoureteral Reflux Management in the Era of Dextranomer/Hyaluronic Acid Copolymer: A Pediatric Health Information System Database Study

Abstract

With the introduction of a new, minimally invasive procedure for reflux therapy the number of procedures for reflux has increased, while open surgery rates have remained stable. This may be explained by public and clinician acceptance of a newer injection material that is safe and increasingly successful. To our knowledge this represents the largest series of patients treated for vesicoureteral reflux in the United States.